WELLESLEY HILLS, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results